Hrt Financial LP Novo Nordisk A S Transaction History

Hrt Financial LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$103.24 - $121.81 $246,124 - $290,395	-2,384 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $1.35 Million - $1.64 Million	-14,547 Reduced 85.92%	2,384 $264,000
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $1.78 Million - $2.17 Million	-18,538 Reduced 52.27%	16,931 $1.9 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $2.99 Million - $3.78 Million	35,469 New	35,469 $3.41 Million
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $2.42 Million - $3.03 Million	-35,695 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $1.58 Million - $1.79 Million	23,604 Added 195.22%	35,695 $2.41 Million
Q4 2020 Feb 16, 2021	BUY	$63.89 - $73.8 $772,493 - $892,315	12,091 New	12,091 $844,000
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $278,400 - $312,196	-5,950 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$46.36 - $52.63 $275,842 - $313,148	5,950 New	5,950 $311,000

1,954

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $237B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.